Table 2.
Treatment-related adverse events
| Adverse event | Any grade (%) | Grade 3/4 (%) |
| Blood and lymphatic | ||
| ITP | 12.5 | 12.5 |
| Leukopenia | 12.5 | – |
| Lymphopenia | 12.5 | – |
| Neutropenia | 12.5 | 12.5 |
| Thrombocytopenia | 12.5 | 12.5 |
| GI/nutrition | ||
| Decreased appetite | 12.5 | – |
| Mouth hemorrhage | 12.5 | – |
| Nausea | 50 | – |
| Taste disorder | 12.5 | – |
| Vomiting | 12.5 | – |
| Investigations | ||
| ALT increase | 37.5 | – |
| AST increase | 37.5 | – |
| General | ||
| Chills | 75 | – |
| Eye disorder | 12.5 | – |
| Fatigue | 62.5 | – |
| Headache | 12.5 | – |
| Hot flashes | 37.5 | – |
| Malaise | 12.5 | 12.5 |
| Night sweats | 12.5 | – |
| Pain | 12.5 | – |
| Fever | 12.5 | – |
| Vascular | ||
| Dizziness | 12.5 | – |
| Hypotension | 12.5 | – |
| Respiratory | ||
| Dyspnea | 12.5 | 12.5 |
| Hypoxia | 12.5 | 12.5 |
| Pneumonitis | 12.5 | 12.5 |
| Cutaneous | ||
| Petechiae | 12.5 | – |
| Pruritus | 25 | – |
| Rash | 25 | – |
ALT, alanine aminotransferase; AST, aspartate transaminase; GI, gastrointestinal; ITP, immune thrombocytopenic purpura.